QC
ONC

Quent Capital’s BeOne Medicines Ltd ONC Stock Holding History

Quent Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$1K – 1374
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1198
2022
Q2 		$1K Hold
5
– – ﹤0.01% 1147
2022
Q1 		$1K Buy
+5
New +$1.06K ﹤0.01% 1241

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quent Capital's ONC Position: Q4 2022 in Review

Quent Capital sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 5 shares — an estimated $1K sold.

Quent Capital first reported a position in ONC in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 213 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • Quent Capital reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • Quent Capital sold 5 BeOne Medicines Ltd shares in Q4 2022, an estimated $1K.
  • Quent Capital first reported a position in BeOne Medicines Ltd in Q1 2022 and held it in 3 quarters.
  • Quent Capital's BeOne Medicines Ltd position peaked at $1K in Q3 2022.
  • 213 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Quent Capital's 13F filing for Q4 2022, filed 19 Jan 2023.